Drug factory · FDA FEI 3002806821

N.V. Organon

Kloosterstraat 6, Oss, Netherlands

Netherlands: 1

No problems found at FDA's last inspection, Sep 8, 2022.

No Action Indicated: inspectors found no objectionable conditions.

11 drug inspections on record since 2009: 7 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
NorethindroneMakes the active ingredient Ohm Laboratories Inc. 51660-127

FDA inspection history

EndedResultProgramProblems noted
Sep 8, 2022No problems foundDrug Quality Assurance—
Aug 25, 2022Problems found, fixed voluntarilyDrug Quality Assurance—
Sep 20, 2019No problems foundDrug Quality Assurance—
Sep 10, 2019No problems foundDrug Quality Assurance—
Sep 7, 2017Problems found, fixed voluntarilyDrug Quality Assurance—
Jun 8, 2016Problems found, fixed voluntarilyDrug Quality Assurance—
Feb 7, 2014Problems found, fixed voluntarilyDrug Quality Assurance—
Apr 5, 2013No problems foundDrug Quality Assurance—
Oct 26, 2012No problems foundDrug Quality Assurance—
Jul 2, 2010No problems foundDrug Quality Assurance—
May 14, 2009No problems foundDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture; label; manufacture; pack; sterilize.